Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Ono

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Ono's Japan sales performance.

China first market to approve AZ’s kidney drug roxadustat

China first market to approve AZ’s kidney drug roxadustat AZ and FibroGen have rights to roxadustat in the US, China and other world markets, while Astellas Pharma will sell the drug in Europe and Japan.

Takeda secures investor backing for £46bn Shire takeover

Takeda secures investor backing for £46bn Shire takeover After a gruelling two and a half hour meeting held in Osaka, Japan, almost 90% of shareholders agreed to the takeover, but the decision was met with some resistance. ... Weber is adamant that Shire will help Takeda grow outside Japan, swelling the

Shire’s angioedema drug Takhzyro claims EU approval

Shire’s angioedema drug Takhzyro claims EU approval EU approval follows a green light in the US in August as well as authorisation in Canada, and is big boost to Shire as well as Japan’s Takeda which is

NHS says Humira biosimilar deal will save £300m

NHS says Humira biosimilar deal will save £300m s Cyltezo and Mylan’s Hulio, the latter sublicensed from Japan’s Fujifilm Kyowa Kirin.

CMC

Establishing our learning and development programme. Highlights included:. Four new global offices established: Japan, Pennsylvania (US), Manchester and Glasgow (both UK), providing a strengthened base on which to build.

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics